A 30-year-old male patient, recently diagnosed with pulmonary tuberculosis, has been on standard antitubercular therapy (ATT) consisting of isoniazid, rifampicin, pyrazinamide, and ethambutol for 2 months. His sputum smear microscopy shows persistent positivity for acid-fast bacilli. The patient’s symptoms, such as cough and fever, have not significantly improved. What would be the next step in managing this patient’s treatment?
He might be resistant to these drugs so antimicrobial susceptibility test should be performed and regimen should be updated accordingly.
•Check TB is drug resistent as no cure after 2 months.
•Conduct drug sensitivity.
•Conveys which drug is sensitive and which one is resistive.
•According to it give the drug to patient and monitor.
•Follow-up treatment.